drug
tagmokitug
Phase 2updated 6mo agoby $CHRS Coherus Oncology, Inc.
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
News(2)
- Coherus cuts 30% of staffers, Gyre makes post-acquisition layoffsCoherus is narrowing its pipeline projects while Gyre reorganizes after an acquisition, with both biotechs conducting workforce reductions.biospace · 6d ago
- Coherus shrinks headcount 30% to narrow focus of cancer comboCoherus Oncology is once again laying off 30% of its workforce as the biopharma narrows the focus of its CCR8-targeting antibody on esophageal cancer.fiercebiotech · 7d ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that